porphobilinogen and arginine

porphobilinogen has been researched along with arginine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's4 (36.36)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jordan, PM; Woodcock, SC1
Goldberg, A; Herrick, AL; McColl, KE; Moore, MR; Wallace, AM1
Lindén, IB; Tenhunen, R; Tokola, O1
Doss, MO; Gross, U; Kühnel, A1
Elder, GH; Hift, RJ1
Feder, ZM; Ignashina, EV; Karpova, IV; Kravchenko, SK; Kremenetskaia, AM; Kurtser, MA; Mironova, TS; Murashko, LE; Petrova, VI; Pustovoĭt, IaS; Pustovoĭt, LA; Shmakov, RG; Shtabnitskiĭ, AM; Sokolova, MIu1
Andersson, DE; Floderus, Y; Harper, P; Sardh, E1
Ma, E; Mar, V; Nicoll, A; Ross, G; Varigos, G1
Badminton, MN; Barth, JH; Cox, TM; Rees, DC; Sarkany, R; Stein, PE; Stewart, MF1
Dosi, R; Joshi, H; Patell, R; Shah, P; Tripathi, R1
Barman-Aksözen, J; Huber, LC; Minder, E; Senn, JD1

Reviews

2 review(s) available for porphobilinogen and arginine

ArticleYear
Treatment of acute porphyria.
    Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:7

    Topics: Adolescent; Adult; Analgesics, Opioid; Arginine; Clinical Trials as Topic; Dietary Carbohydrates; Female; Heme; Humans; Male; Porphobilinogen; Porphyria, Acute Intermittent; Pregnancy; Pregnancy Complications; Treatment Outcome

2001
[CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?]
    Praxis, 2018, Volume: 107, Issue:3

    Topics: Arginine; Combined Modality Therapy; Diagnosis, Differential; Female; Genetic Predisposition to Disease; Heme; Hemin; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Middle Aged; Porphobilinogen; Porphyria, Acute Intermittent; Prognosis; Recurrence; Risk Factors

2018

Trials

1 trial(s) available for porphobilinogen and arginine

ArticleYear
Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    European journal of internal medicine, 2009, Volume: 20, Issue:2

    Topics: Acute Disease; Adult; Aminolevulinic Acid; Arginine; Biomarkers; Chromatography, Ion Exchange; Drug Monitoring; Female; Glucose; Heme; Humans; Male; Porphobilinogen; Porphyria, Acute Intermittent; Sensitivity and Specificity

2009

Other Studies

8 other study(ies) available for porphobilinogen and arginine

ArticleYear
Mutagenesis of arginine residues in the catalytic cleft of Escherichia coli porphobilinogen deaminase that affects dipyrromethane cofactor assembly and tetrapyrrole chain initiation and elongation.
    The Biochemical journal, 1991, Dec-01, Volume: 280 ( Pt 2)

    Topics: Amino Acid Sequence; Arginine; Catalysis; Chromatography, Liquid; Escherichia coli; Hydroxymethylbilane Synthase; Kinetics; Molecular Sequence Data; Mutagenesis; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Porphobilinogen; Pyrroles; Tetrapyrroles

1991
Elevation of hormone-binding globulins in acute intermittent porphyria.
    Clinica chimica acta; international journal of clinical chemistry, 1990, Feb-28, Volume: 187, Issue:2

    Topics: Adolescent; Adult; Aminolevulinic Acid; Arginine; Carrier Proteins; Heme; Humans; Hydrocortisone; Liver Diseases; Porphobilinogen; Porphyrias; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins

1990
The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
    Pharmacology & toxicology, 1987, Volume: 61, Issue:1

    Topics: 5-Aminolevulinate Synthetase; Allylisopropylacetamide; Animals; Arginine; Heme; Hemin; Liver; Male; Porphobilinogen; Porphyrias; Rats; Rats, Inbred Strains

1987
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients.
    Clinical biochemistry, 2000, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Arginine; Child; Chromatography, High Pressure Liquid; Coproporphyrinogen Oxidase; Coproporphyrins; Feces; Female; Germany; Heme; Heterozygote; Humans; Isomerism; Male; Middle Aged; Porphobilinogen; Porphyrias, Hepatic; Uroporphyrins

2000
[Management of pregnancy in women with acute porphyria. Case reports].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:8

    Topics: Adult; Arginine; Female; Follow-Up Studies; Heme; Humans; Infant, Newborn; Male; Porphobilinogen; Porphyria, Acute Intermittent; Porphyrins; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors

2007
Haem arginate as effective maintenance therapy for hereditary coproporphyria.
    The Australasian journal of dermatology, 2011, Volume: 52, Issue:2

    Topics: Abdominal Pain; Adult; Arginine; Coproporphyria, Hereditary; Female; Heme; Humans; Photosensitivity Disorders; Porphobilinogen; Severity of Illness Index; Treatment Outcome

2011
Acute intermittent porphyria: fatal complications of treatment.
    Clinical medicine (London, England), 2012, Volume: 12, Issue:3

    Topics: Abdominal Pain; Adolescent; Analgesics; Arginine; Disease Management; Fatal Outcome; Female; Hallucinations; Heme; Humans; Hyponatremia; Monitoring, Physiologic; Porphobilinogen; Porphyria, Acute Intermittent; Water-Electrolyte Balance

2012
Challenges in the successful management of a case of acute intermittent porphyria in India.
    Tropical doctor, 2016, Volume: 46, Issue:3

    Topics: Abdominal Pain; Administration, Intravenous; Adolescent; Arginine; Heme; Humans; India; Male; Porphobilinogen; Porphyria, Acute Intermittent; Seizures; Treatment Outcome

2016